Clinical predictors of long-term efficacy of first-line pembrolizumab monotherapy in non-small cell lung cancer (NSCLC): an interim analysis of real-world data. (March 2022)

• Record Type: Journal Article
• Authors: Younan, Helen-Cara; Zhang, Shuai; Monroy, Maria; Almusarhed, Manar; Julve, Max; Roy, Debashree; Toghey, Sopozme; Ahmed, Zartaj; Slater, Stephanie; Altharwane, Shaymaa; Giorgiou, Alex; Ghosh, Sharmistha; Gennatas, Spyridon; Karapanagiotou, Eleni; Montes, Ana; Pintus, Elias; Spicer, James; Shah, Riyaz; Ahmed, Samreen; Newsom-Davis, Tom; Mohammed, Waleed; Power, Danielle; Evans, Joanne; Hatcher, Olivia; Lakhani, Amish; Samani, Amit; Josephs, Debra
• Is Part Of: Lung cancer. Volume 165(2022)Supplement 1
• Page Start: S32
• Publication Date: 2022-03
• Subjects: Lungs -- Cancer -- Periodicals; Lung Neoplasms -- Abstracts; Lung Neoplasms -- Periodicals; Poumons -- Cancer -- Périodiques; Lungs -- Cancer; Periodicals; Electronic journals; Electronic journals; 616.99424
• DOI: 10.1016/S0169-5002(22)00113-1
• Languages: English
• ISSNs: 0169-5002